GrimAge2logA1c

There is 1 paper on GrimAge2logA1c in aging research: 1 observational study in people. The newest story, Nov 9, 2026: “DNA aging patterns differ across type 2 diabetes groups”.

Biomarker

1 paper studies it1 finding

See all 1 papers on GrimAge2logA1c

“GrimAge2logA1c was both highest in SIRD-RII and the only clock associated with kidney function decline (eGFR slope, β [SE] = -0.113 [0.040], p = 4.77 × 10−3).”
Distinct epigenetic ageing patterns are associated with heterogeneity in kidney function decline in type 2 diabetesGeroScience2026doi:10.1007/s11357-026-02396-4
  • Humans1

Associations

1

eGFR slope

downin humans1

1 study
  1. GrimAge2logA1c predicts eGFR slope in type 2 diabetes (β = -0.113, p = 4.77 × 10−3).

    “GrimAge2logA1c was both highest in SIRD-RII and the only clock associated with kidney function decline (eGFR slope, β [SE] = -0.113 [0.040], p = 4.77 × 10−3).”

    Humansin type 2 diabetes7.3 yearsn = 607

    DNA aging patterns differ across type 2 diabetes groups

    GeroScience

More on eGFR slope

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 1Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months
GeroScience

DNA aging patterns differ across type 2 diabetes groups

An observational study of 607 multi-ethnic Asians linked one DNA-based aging measure to kidney function decline over a median 7.3 years.An observational study of 607 multi-ethnic Asians linked one DNA-based aging measure to kidney function decline over a median 7.3 years.

Cohort · 607 peopleType 2 diabetes